Online Program

Coalition Building to Address Hepatitis B in Asian American and Pacific Islander Communities

Tuesday, November 3, 2015

Kate Moraras, MPH, Department of Public Health Research, Hepatitis B Foundation, Doylestown, PA
Joan Block, RN, BSN, Hepatitis B Foundation, Doylestown, PA
Jeffrey Caballero, MPH, Association of Asian Pacific Community Health Organizations, Oakland, CA
Pavitri Dwivedi, MPH, Hepatitis B Foundation, Doylestown, PA
Allan Gamboa, Association of Asian Pacific Community Health Organizations, Oakland, CA
Melinda Martin, MPH, Association of Asian and Pacific Islander Community Health Organizations (AAPCHO), Oakland,, CA
Michelle Ninde, MA, Association of Asian Pacific Community Health Organizations, Oakland, CA
Isha Weerasinghe, MSc, Hepatitis B Policy, Association for Asian Pacific Community Health Organizations, Washington, DC
Chari Cohen, DrPH, MPH, Department of Public Health Research, Hepatitis B Foundation, Doylestown, PA
Background: In the United States, Asian Americans and Pacific Islanders (AAPI) are disproportionately impacted by hepatitis B (HBV), a disease that is silent and largely undiagnosed, but preventable and treatable. Chronic hepatitis B can slowly destroy the liver over many years, increasing the risk of serious diseases. Approximately 1 million AAPIs are living with chronic HBV infection - more than half of all cases in the United States. First-generation Asians from China, Korea and Vietnam and individuals from the Pacific Islands are at particularly high risk for HBV due to low infant immunization rates in those countries. Over 20 community-based organizations representing 14 states and the District of Columbia united in a national coalition to address this public health priority. The coalition is comprised of multi-sectoral collaborations serving AAPI communities, many who are immigrants and refugees and are limited English proficient and linguistically isolated.

Objective/Purpose: A capacity building program was developed to improve coordination, increase resource sharing/education, and partner engagement. Components include a peer mentoring program, in-person conferences, online trainings, one-on-one technical assistance, and policy advocacy engagement.

Methods: An initial and follow-up survey of the national coalition was conducted to measure member engagement and improved capacity, resources, and education to address HBV in AAPI communities.

Results: Coalition building was successful in increased engagement, resources, and infrastructure development. Members continue to face resource constraints balancing HBV programs with other public health programs; the coalition will have to overcome these barriers and find innovative strategies to sustain member engagement.

Learning Areas:

Advocacy for health and health education
Communication and informatics
Implementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs
Public health or related public policy
Systems thinking models (conceptual and theoretical models), applications related to public health

Learning Objectives:
Explain the disproportionate impact of hepatitis B on Asian American and Pacific Islander immigrant and refugee communities. Describe national collaborations to address hepatitis B-related health disparities. Identify key strategies for building and sustaining a public health coalition.

Keyword(s): Hepatitis B, Community-Based Partnership & Collaboration

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have managed programs focused on addressing chronic hepatitis B-related health disparities in immigrant and refugee communities. Among my interests have been the development of national program and policy strategies for reducing racial and ethnic minority disparities in health.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.